» Articles » PMID: 37445846

Neurotoxicity from Old and New Radiation Treatments for Brain Tumors

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jul 14
PMID 37445846
Authors
Affiliations
Soon will be listed here.
Abstract

Research regarding the mechanisms of brain damage following radiation treatments for brain tumors has increased over the years, thus providing a deeper insight into the pathobiological mechanisms and suggesting new approaches to minimize this damage. This review has discussed the different factors that are known to influence the risk of damage to the brain (mainly cognitive disturbances) from radiation. These include patient and tumor characteristics, the use of whole-brain radiotherapy versus particle therapy (protons, carbon ions), and stereotactic radiotherapy in various modalities. Additionally, biological mechanisms behind neuroprotection have been elucidated.

Citing Articles

Does Personality Influence the Quality of Life of Patients with Brain Tumors Treated with Radiotherapy?.

Pilarska A, Pieczynska A, Adamska K, Hojan K Cancers (Basel). 2025; 17(1.

PMID: 39796758 PMC: 11719694. DOI: 10.3390/cancers17010131.


Ferroptosis in radiation-induced brain injury: roles and clinical implications.

Li L, Liu X, Han C, Tian L, Wang Y, Han B Biomed Eng Online. 2024; 23(1):93.

PMID: 39261942 PMC: 11389269. DOI: 10.1186/s12938-024-01288-y.


A brain metastasis liquid biopsy: Where are we now?.

Robinson S, de Boisanger J, Pearl F, Critchley G, Rosenfelder N, Giamas G Neurooncol Adv. 2024; 6(1):vdae066.

PMID: 38770219 PMC: 11102938. DOI: 10.1093/noajnl/vdae066.


Comparable survival in rats with intracranial glioblastoma irradiated with single-fraction conventional radiotherapy or FLASH radiotherapy.

Liljedahl E, Konradsson E, Linderfalk K, Gustafsson E, Petersson K, Ceberg C Front Oncol. 2024; 13:1309174.

PMID: 38322292 PMC: 10845047. DOI: 10.3389/fonc.2023.1309174.


Copper induces neuron-sparing, ferredoxin 1-independent astrocyte toxicity mediated by oxidative stress.

Gale J, Hartnett-Scott K, Ross M, Rosenberg P, Aizenman E J Neurochem. 2023; 167(2):277-295.

PMID: 37702109 PMC: 10591933. DOI: 10.1111/jnc.15961.

References
1.
Gondi V, Mehta M . Novel insights into the management of brain metastases. Curr Opin Neurol. 2010; 23(6):556-62. DOI: 10.1097/WCO.0b013e32833f8cb5. View

2.
Cacao E, Cucinotta F . Modeling Heavy-Ion Impairment of Hippocampal Neurogenesis after Acute and Fractionated Irradiation. Radiat Res. 2016; 186(6):624-637. PMC: 5545979. DOI: 10.1667/RR14569.1. View

3.
Heckl S, Aschoff A, Kunze S . Radiation-induced cavernous hemangiomas of the brain: a late effect predominantly in children. Cancer. 2002; 94(12):3285-91. DOI: 10.1002/cncr.10596. View

4.
Paulino A, Ludmir E, Grosshans D, Su J, McGovern S, Okcu M . Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. Cancer. 2021; 127(20):3865-3871. DOI: 10.1002/cncr.33783. View

5.
Feiock C, Yagi M, Maidman A, Rendahl A, Hui S, Seelig D . Central Nervous System Injury - A Newly Observed Bystander Effect of Radiation. PLoS One. 2016; 11(9):e0163233. PMC: 5045183. DOI: 10.1371/journal.pone.0163233. View